FDA Press Releases RSS Feed

  • Coronavirus (COVID-19) Update: Daily Roundup August 6, 2020

    Coronavirus (COVID-19) Update: Daily Roundup August 6, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup August 5, 2020

    Coronavirus (COVID-19) Update: Daily Roundup August 5, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup August 4, 2020

    Coronavirus (COVID-19) Update: Daily Roundup August 4, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • La FDA les recomienda a los consumidores que eviten las cebollas rojas de un proveedor en California; la investigación continúa para encontr

    La FDA les recomienda a los consumidores que eviten las cebollas rojas de un proveedor en California; la investigación continúa para encontr

    La FDA les recomienda a los consumidores que eviten las cebollas rojas de un proveedor en California; la investigación continúa para encontrar la fuente.

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup August 3, 2020

    Coronavirus (COVID-19) Update: Daily Roundup August 3, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

    FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

    The FDA has approved a new indication for drug to treat seizures associated with tuberous sclerosis complex.

    Learn More
  • Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection

    Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection

    Today, the U.S. Food and Drug Administration authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 31, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 31, 2020

    FDA's actions on July 31, 2020 in its ongoing response to the COVID-19 pandemic.

    Learn More
  • FDA Announces Voluntary Agreement with Manufacturers to Phase Out Certain Short-Chain PFAS Used in Food Packaging

    FDA Announces Voluntary Agreement with Manufacturers to Phase Out Certain Short-Chain PFAS Used in Food Packaging

    The FDA is announcing that the manufacturers of certain per- and polyfluoroalkyl substances (PFAS) used for grease-proofing in paper and paperboard for food packaging have voluntarily agreed to...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 30, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 30, 2020

    FDA's actions on July 30, 2020in the ongoing response to the COVID-19 pandemic

    Learn More
  • FDA Announces New Protocol for the Development and Registration of Treatments for Preharvest Agricultural Water

    FDA Announces New Protocol for the Development and Registration of Treatments for Preharvest Agricultural Water

    The FDA announced a new protocol for the development and registration of antimicrobial treatments for preharvest agricultural water, such as the water used in farm irrigation systems.

    Learn More
  • FDA Warns Companies Illegally Selling Hangover Remedies

    FDA Warns Companies Illegally Selling Hangover Remedies

    FDA has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers.

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 29, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 29, 2020

    FDA actions on July 29, 2020 on updated molecular diagnostic templates for labs and industry preparing EUA requests, templates for commercial developers submitting EUA requests for at-home...

    Learn More
  • Coronavirus (COVID-19) Update: FDA Posts New Template for At-Home and Over-the-Counter Diagnostic Tests for Use in Non-Lab Settings, Such as

    Coronavirus (COVID-19) Update: FDA Posts New Template for At-Home and Over-the-Counter Diagnostic Tests for Use in Non-Lab Settings, Such as

    The FDA has posted a new template for commercial developers to submit emergency use authorization (EUA) requests for COVID-19 diagnostic tests that can be performed entirely at home or in other...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 28, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 28, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 27, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 27, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Coronavirus (COVID-19) Update: FDA Reiterates Warning About Dangerous Alcohol-Based Hand Sanitizers Containing Methanol, Takes Additional Ac

    Coronavirus (COVID-19) Update: FDA Reiterates Warning About Dangerous Alcohol-Based Hand Sanitizers Containing Methanol, Takes Additional Ac

    FDA continues to warn consumers and health care professionals not to use certain alcohol-based hand sanitizers due to the dangerous presence of methanol

    Learn More
  • Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection

    Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection

    The U.S. Food and Drug Administration reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use: testing for people who do not have...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup July 24, 2020

    Coronavirus (COVID-19) Update: Daily Roundup July 24, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

    FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

    FDA approves first cell-based gene therapy to treat adult patients with MCL who have not responded to or who have relapsed following other kinds of treatment.

    Learn More
  • loading
    Loading More...